Cyclooxygenase-2 selective inhibitors and prostate cancer: What is the clinical benefit?

Raymond N. DuBois

doi:10.1200/JCO.2006.05.9709

Cyclooxygenase-2 selective inhibitors and prostate cancer: What is the clinical benefit?

Raymond N. DuBois

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	2691-2693
Number of pages	3
Journal	Journal of Clinical Oncology
Volume	24
Issue number	18
DOIs	https://doi.org/10.1200/JCO.2006.05.9709
State	Published - Jun 20 2006

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2006.05.9709

Cite this

@article{520f85d641e6473fb516c0db44ee72a1,

title = "Cyclooxygenase-2 selective inhibitors and prostate cancer: What is the clinical benefit?",

author = "DuBois, {Raymond N.}",

year = "2006",

month = jun,

day = "20",

doi = "10.1200/JCO.2006.05.9709",

language = "English (US)",

volume = "24",

pages = "2691--2693",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "18",

}

TY - JOUR

T1 - Cyclooxygenase-2 selective inhibitors and prostate cancer

T2 - What is the clinical benefit?

AU - DuBois, Raymond N.

PY - 2006/6/20

Y1 - 2006/6/20

UR - http://www.scopus.com/inward/record.url?scp=33745578642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745578642&partnerID=8YFLogxK

U2 - 10.1200/JCO.2006.05.9709

DO - 10.1200/JCO.2006.05.9709

M3 - Editorial

C2 - 16782907

AN - SCOPUS:33745578642

SN - 0732-183X

VL - 24

SP - 2691

EP - 2693

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 18

ER -

Cyclooxygenase-2 selective inhibitors and prostate cancer: What is the clinical benefit?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this